Trials
The Tack Optimized Balloon Angioplasty (TOBA) trials demonstrate that the Tack Endovascular System®, when combined with any form of balloon angioplasty, improves outcomes and reduces revascularization. Review the results of the first and only trials to investigate 100% dissected vessels.
TOBA II BTK data demonstrates 100% dissection resolution in challenging BTK vessels in a first-of-its-kind pivotal study. Dr. Adams presents the study results.
Vascular News interview with Dr. George Adams following the late-breaking clinical trial presentation of the TOBA II BTK study results.
Drs. Adams and Geraghty discuss the TOBA II BTK study results, moderated by Dr. Gray
Drs. Zeller, Brodmann and Lichtenberg discuss the TOBA III study results
TOBA III demonstrates some of the highest reported rates of safety, patency, and freedom from CD-TLR.
Drs. Gray and Zeller discuss the TOBA II study results.
TOBA II demonstrates that the Tack Endovascular System, when combined with POBA or DCB, improves outcomes and reduces revascularization. Dr. Gray presents the study results.
